Dengue Fever Market Report 2023-2033 | Industry Size, Growth and Latest Insights

Dengue Fever Market Report Overview:
Report Attribute Details
Base Year 2022
Forecast Years 2023-2033
Historical Years 2017-2022
Market Growth (2023-2033) 10.64%

The report offers a comprehensive analysis of the dengue fever market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market's performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the dengue fever market.

Request for a Sample Copy of this Report: https://www.imarcgroup.com/dengue-fever-market/requestsample

Market Overview:

The 7 major dengue fever markets are expected to exhibit a CAGR of 10.64% during 2023-2033. The dengue fever market is expanding due to the rise in viral infections that cause microbes to infiltrate and reproduce in the human body. The growth is also fueled by inadequate sanitation and ineffective waste management, which increase mosquito breeding sites and spread the virus. The escalating adoption of potent analgesics like acetaminophen and , which alleviate symptoms such as fever, headaches, and musculoskeletal pain, further contributes to market expansion.

The rising trend of using intravenous fluids for patients unable to take oral medicines enhances organ function, maintains hydration, and balances electrolytes, thus stimulating market growth. The growing demand for mosquito repellent creams with high concentrations of N, N-diethyl-meta-toluamide, or picaridin, which provide long-term protection against infection, is projected to boost the dengue fever market in future years.

Countries Covered:

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan

Analysis Covered Across Each Country:

• Historical, current, and future epidemiology
scenario
• Historical, current, and future performance of the
dengue fever market
• Historical, current, and future performance of
various therapeutic categories in the market
• Sales of various drugs across the dengue fever
market
• Reimbursement scenario in the market
• In-market and pipeline drugs

This report also provides a detailed analysis of the current dengue fever marketed drugs and late-stage pipeline drugs.

In-Market Drugs:

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance

Late-Stage Pipeline Drugs:

• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance

Competitive Landscape With Key Players:

The competitive landscape of the dengue fever market has been studied in the report with the detailed profiles of the key players operating in the market.

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=8418&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.